Cover Story »
Thu, 01/12/2012 - 15:28
Skin Cancer Review

An update on recent news, research and treatment trends for skin cancer.

UCLA researchers have genetically engineered blood stem cells to fight melanoma, and the identification of a mechanism of resistance to vemurafenib (Zelboraf), the melanoma drug approved in April 2011, could enable researchers to develop additional treatments and recommend combinations of vemurafenib and other drugs that can overcome this resistance.

Read the full story
First Report® Dermatology News
more news

Dermatology Topics »

Skin Cancer/Photoaging

Current and archived articles.
Search sponsored by:

Rosacea

All rosacea-related content from current research reviews to tips on treating patients dealing with this condition.

Practice Management

Content related to running a successful practice, such as solutions for common business problems, legal issues, electronic health records and coding.

Acne

All acne-related content on treatments, patient compliance issues, acne scarring and more.

Fungal Infections

Current and archived articles involving treatment and prevention of fungal infections

Psoriasis

All articles covering all types of psoriasis, including plaque, guttate, inverse, pustular and erythrodermic.

Pediatric Dermatology

Content dealing with pediatric skin issues, such as hemangiomas, MRSA, atopic dermatitis, contact dermatitis, etc.

Eczema

Current and archived articles.
Search sponsored by:

Cosmetic Dermatology

Current and archived articles.
Search sponsored by:

Laser & Light Therapies

Articles highlighting various treatments with lasers and light therapies as well as pre- and post-op care.

Online Exclusive »

Skin Advocate App Provides All-inclusive Location for Patient Advocacy Groups, Makes Referrals Easy
Fri, 01/13/2012 - 10:59
0 Comments
241 views

The Skin Advocate app is designed to streamline patient advocacy and support groups in one place. The app serves a two-fold purpose — enabling physicians to share information with patients about advocacy groups more easily and providing patients with an increased amount of resources for dealing with a skin condition. It is also designed as a tool to improve the office visit and patient outcomes.

Read the full story

Feature »

Treating Rare Fungal Infections: Coccidioidomycosis
Thu, 01/12/2012 - 12:32
0 Comments
331 views

Coccidioidomycosis is caused by the highly infectious, dimorphic fungus Coccidioides immitis. The broad clinical presentation of coccidioidomycosis was appreciated in the 1930s, when it was identified as the etiologic pathogen of “Valley fever” in the San Joaquin Valley in California. Cutaneous involvement is generally secondary to disseminated disease but can represent primary disease from direct inoculation. Systemic involvement, especially in immunocompromised hosts, has a poor prognosis, warranting timely diagnosis and prompt management.

Read the full story

Feature »

Pharmaceutical Payments to Doctors Posted Online
Thu, 01/12/2012 - 11:51
0 Comments
310 views

The 2010 healthcare reform law contains provisions for posting pharmaceutical company compensation to doctors online. Fees could include those paid for participation on a speaker’s bureau, consulting, research and attending dinner. A backlash is already building toward doctors who are perceived as gluttonous and easily bought, and patients are venting their concerns in online forums.

This feature discusses how the online posting of all fees paid to physicians by industry may affect the medical field.

Read the full story
Departments »
Doctor-Patient Communication: Sometimes Less is More
01/13/2012
An inside look at dermatology issues from Steven R. Feldman, MD, PhD.
News and Trends
01/13/2012
FDA Approvals and News
What Caused This Erythema and Scaling?
01/12/2012
Can you make this diagnosis by studying the photo and case history?
Classifieds & Recruitments
more »
Skin & Aging Monthly Poll
Will You Be Attending the 2012 Annual American Academy of Dermatology Meeting?: